• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿司匹林预防的低风险和高风险子痫前期组从孕早期到孕中期子宫胎盘灌注发育的比较

Comparison of Utero-Placental Perfusion Development From First to Second Trimester Between Low-Risk and High-Risk Pre-eclampsia Groups With Aspirin Prophylaxis.

作者信息

Ritgen Jochen, Roxin Julia, Kolsch Marit, Bergsch Arne, Degenhardt Jan

机构信息

Center for Prenatal Medicine and Genetics, Praenatal Plus, Cologne, DEU.

Medical Department, Justus-Liebig-University, Giessen, DEU.

出版信息

Cureus. 2024 Jun 13;16(6):e62309. doi: 10.7759/cureus.62309. eCollection 2024 Jun.

DOI:10.7759/cureus.62309
PMID:39006731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245960/
Abstract

Introduction Pre-eclampsia (PE) is a common diagnosis in pregnancy and affects pregnancies worldwide. Early-onset PE often leads to severe maternal and fetal complications. Prophylactic use of aspirin (150 mg/day) before the 16th week of pregnancy can reduce the risk of PE. This study aimed to investigate the effects of maternal factors on the development of uteroplacental perfusion and fetal biometry from the first to the second trimester in a risk group receiving aspirin prophylaxis compared to a control group without Aspirin. Methods This case-control study included 448 women at high risk for PE (risk group, RG) receiving aspirin prophylaxis and 468 women at low PE risk without aspirin intake (control group, CG). Parameters recorded and considered in the first (T1) and second (T2) trimesters included uterine artery pulsatility multiple of the median (UtAPI MoM), notching at T1 and T2 and fetal biometry parameters at T2. Maternal factors were also captured, and their respective effects were examined. Results UtAPI MoM at T1 and T2 showed a significant positive correlation (r = 0.39, p < 0.001), with UtAPI MoM at T2 significantly higher for notching "yes" at T1. Pre-existing arterial hypertension and UtAPI development demonstrated a significant association (p = 0.006). Women without this risk factor showed a significantly (p < 0.001) greater decline in UtAPI development. The likelihood of notching "yes" at T2 (p < 0.001; OR: 5.80) was increased with higher UtAPI MoM at T1. The mean values (T1 and T2) of UtAPI MoM were significantly higher in the risk group than in the control group. Patients in the risk group exhibited notching at T2 (p < 0.001; OR: 5.64) more often compared to the control group. The 95% CI of the estimated fetal weight for notching "yes" at T1 was below the 50th percentile. Gestational age and head circumference/abdomen circumference (HC/AC) ratio showed a significant negative correlation (p < 0.001; b = -0.01). The control group showed significantly higher estimated fetal weights than the risk group. The HC/AC ratio in the risk group was above the HC/AC ratio in the control group but without proving significance. Conclusions Persistent notching and elevated UtAPI MoM levels in the second trimester may be risk factors for early-onset PE. Women with pre-existing arterial hypertension, notching and elevated UtAPI MoM values ​​in the first and second trimesters require special monitoring during the course of pregnancy.

摘要

引言 子痫前期(PE)是孕期常见的诊断疾病,影响着全球各地的妊娠。早发型PE常导致严重的母婴并发症。在妊娠16周前预防性使用阿司匹林(150毫克/天)可降低PE风险。本研究旨在调查与未使用阿司匹林的对照组相比,在接受阿司匹林预防的风险组中,孕早期至孕中期母体因素对子宫胎盘灌注发育和胎儿生物测量的影响。

方法 本病例对照研究纳入了448名接受阿司匹林预防的PE高危女性(风险组,RG)和468名未摄入阿司匹林的低PE风险女性(对照组,CG)。在孕早期(T1)和孕中期(T2)记录并考虑的参数包括子宫动脉搏动指数中位数倍数(UtAPI MoM)、T1和T2时的切迹以及T2时的胎儿生物测量参数。还记录了母体因素,并检查了它们各自的影响。

结果 T1和T2时的UtAPI MoM呈显著正相关(r = 0.39,p < 0.001),T1时切迹为“是”的T2时UtAPI MoM显著更高。既往动脉高血压与UtAPI发育呈显著关联(p = 0.006)。无此风险因素的女性UtAPI发育下降幅度显著更大(p < 0.001)。T1时UtAPI MoM越高,T2时切迹为“是”的可能性越大(p < 0.001;OR:5.80)。风险组中UtAPI MoM的平均值(T1和T2)显著高于对照组。与对照组相比,风险组患者T2时出现切迹的情况更频繁(p < 0.001;OR:5.64)。T1时切迹为“是”的估计胎儿体重的95%置信区间低于第50百分位数。孕周与头围/腹围(HC/AC)比值呈显著负相关(p < 0.001;b = -0.01)。对照组的估计胎儿体重显著高于风险组。风险组的HC/AC比值高于对照组,但未显示出显著性。

结论 孕中期持续的切迹和升高的UtAPI MoM水平可能是早发型PE的危险因素。在妊娠期间,患有既往动脉高血压、孕早期和孕中期有切迹以及UtAPI MoM值升高的女性需要特别监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6946/11245960/c630b05ceecd/cureus-0016-00000062309-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6946/11245960/c630b05ceecd/cureus-0016-00000062309-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6946/11245960/c630b05ceecd/cureus-0016-00000062309-i01.jpg

相似文献

1
Comparison of Utero-Placental Perfusion Development From First to Second Trimester Between Low-Risk and High-Risk Pre-eclampsia Groups With Aspirin Prophylaxis.阿司匹林预防的低风险和高风险子痫前期组从孕早期到孕中期子宫胎盘灌注发育的比较
Cureus. 2024 Jun 13;16(6):e62309. doi: 10.7759/cureus.62309. eCollection 2024 Jun.
2
ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.ASPRE 试验:尽管进行了阿司匹林预防,早产子痫前期发展的风险因素。
Ultrasound Obstet Gynecol. 2021 Oct;58(4):546-552. doi: 10.1002/uog.23668. Epub 2021 Sep 6.
3
Routine first-trimester pre-eclampsia screening and risk of preterm birth.常规早孕期子痫前期筛查与早产风险。
Ultrasound Obstet Gynecol. 2022 Aug;60(2):185-191. doi: 10.1002/uog.24915. Epub 2022 Jun 22.
4
Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.基于 19-24 孕周子宫动脉多普勒评估的子痫前期风险对妊娠进行分层。
Ultrasound Obstet Gynecol. 2021 Jul;58(1):67-76. doi: 10.1002/uog.23623. Epub 2021 Jun 9.
5
Obstetrical complications associated with abnormal maternal serum markers analytes.与母体血清标志物分析物异常相关的产科并发症。
J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5.
6
Ophthalmic artery Doppler at 19-23 weeks' gestation in pregnancies that deliver small-for-gestational-age neonates.19-23 孕周胎儿眼动脉多普勒在小于胎龄儿分娩孕妇中的应用。
Ultrasound Obstet Gynecol. 2022 Jul;60(1):52-58. doi: 10.1002/uog.24913. Epub 2022 Jun 3.
7
Effects of early aspirin therapy on utero-placental hemodynamics in patients at risk of preeclampsia.早孕期阿司匹林治疗对子痫前期高危患者子宫胎盘血流动力学的影响。
J Matern Fetal Neonatal Med. 2022 Jun;35(12):2304-2310. doi: 10.1080/14767058.2020.1786048. Epub 2020 Jul 30.
8
Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.孕 36 周胎儿偏小孕妇的眼动脉多普勒与胎盘功能不良的生物标志物。
Ultrasound Obstet Gynecol. 2024 Mar;63(3):358-364. doi: 10.1002/uog.27521. Epub 2024 Feb 10.
9
Uterine Artery Pulsatility Index as a Pre-eclampsia Predictor in the 3 Trimesters in Women with Singleton Pregnancies.子宫动脉搏动指数在单胎妊娠女性中预测子痫前期的作用:3 个孕期的分析。
Rev Bras Ginecol Obstet. 2021 Dec;43(12):904-910. doi: 10.1055/s-0041-1740273. Epub 2021 Dec 21.
10
Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population.在一个本土南亚人群中,胎儿医学基金会算法进行早孕期子痫前期筛查的表现。
BMC Pregnancy Childbirth. 2021 Dec 4;21(1):805. doi: 10.1186/s12884-021-04283-6.

本文引用的文献

1
Is blood pressure 120-139/80-89 mmHg before 20 weeks a risk factor for hypertensive disorders of pregnancy? A meta-analysis.20 周前血压 120-139/80-89mmHg 是否是妊娠高血压疾病的危险因素?一项荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2023 May;284:66-75. doi: 10.1016/j.ejogrb.2023.03.011. Epub 2023 Mar 15.
2
Defining the risk profile of women with stage 1 hypertension: a time to event analysis.定义 1 期高血压女性的风险特征:时间事件分析。
Am J Obstet Gynecol MFM. 2021 Jul;3(4):100376. doi: 10.1016/j.ajogmf.2021.100376. Epub 2021 Apr 18.
3
Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions.
母体肥胖和妊娠期糖尿病对胎盘的影响:现有知识和治疗干预靶点。
Curr Vasc Pharmacol. 2021;19(2):176-192. doi: 10.2174/1570161118666200616144512.
4
Maternal Obesity and the Risk of Early-Onset and Late-Onset Hypertensive Disorders of Pregnancy.母亲肥胖与早发型和晚发型妊娠高血压疾病风险的关系。
Obstet Gynecol. 2020 Jul;136(1):118-127. doi: 10.1097/AOG.0000000000003901.
5
Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women.血压轨迹和类别与初产妇妊娠高血压疾病的风险。
Am J Obstet Gynecol. 2019 Sep;221(3):277.e1-277.e8. doi: 10.1016/j.ajog.2019.06.031. Epub 2019 Jun 27.
6
Predictive performance of the competing risk model in screening for preeclampsia.竞争风险模型在子痫前期筛查中的预测性能。
Am J Obstet Gynecol. 2019 Feb;220(2):199.e1-199.e13. doi: 10.1016/j.ajog.2018.11.1087. Epub 2018 Nov 14.
7
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.美国妇产科医师学会委员会意见 No.743:孕期低剂量阿司匹林的应用。
Obstet Gynecol. 2018 Jul;132(1):e44-e52. doi: 10.1097/AOG.0000000000002708.
8
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.阿司匹林用于预防早产和足月子痫前期:系统评价和荟萃分析。
Am J Obstet Gynecol. 2018 Mar;218(3):287-293.e1. doi: 10.1016/j.ajog.2017.11.561. Epub 2017 Nov 11.
9
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.基于证据的阿司匹林预防子痫前期试验:根据女性的特征以及内科和产科病史,阿司匹林在预防早产子痫前期亚组中的作用。
Am J Obstet Gynecol. 2017 Nov;217(5):585.e1-585.e5. doi: 10.1016/j.ajog.2017.07.038. Epub 2017 Aug 4.
10
Pregnancy-Related Mortality in the United States, 2011-2013.2011 - 2013年美国与妊娠相关的死亡率
Obstet Gynecol. 2017 Aug;130(2):366-373. doi: 10.1097/AOG.0000000000002114.